Health
Researchers create AI system that matches tumors to best drug combinations – News-Medical.net
Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).
Reviewed by Emily Henderson, B.Sc.Oct 23 2020
Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).
That’s because right now we can’t match the right combination of drugs to the right patients in a smart way. And especially for cancer, where we can’t always predict which drugs will work best given the unique, complex inner workings of a person’s tumor cells.”
Trey Ideker, PhD, Professor, School of Medicine and Moores…
-
Noosa News23 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News22 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General18 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Business9 hours agoFord CEO makes stunning prediction about artificial intelligence